Repsol signs 30.5-MW virtual power contract with Charles River in Spain

Spanish energy and petrochemical company Repsol SA entered into a virtual power purchase agreement to supply 30.5 MW associated with a planned wind farm in Spain to pharmaceutical firm Charles River Laboratories International Inc.

The wind farm is part of Repsol's Delta II project, which upon completion is expected to have a total capacity of 860 MW across 26 wind farms located in the eastern Spanish region of Aragon. The wind farm is scheduled to be completed in 2023, according to a Feb. 3 news release.

Charles River is a U.S.-headquartered early-stage contract research company that provides drug discovery, development and testing services.

"Charles River has continued to drive down our Scope 1 and 2 [greenhouse gas] reductions toward our goal of a 50% reduction on an absolute basis by 2030, achieving a 26% reduction from 2018 to 2020," Charles River Senior Director of EHS & Sustainability Gregg Belardo said in the news release. "This European [virtual power purchase agreement] will move us significantly closer to meeting our overall goal of a 50% reduction by 2030."

In October 2021, Repsol announced plans to allocate an additional €1 billion to low-carbon projects, raising the total to €6.5 billion from the €5.5 billion set out in the company's strategic plan approved in November 2020.